Jan. 5, 2007 — A French court has ruled that Abbott Laboratories’ Xience V drug-eluting coronary stents infringe patents ...
The Emboshield PRO Embolic Protection System received CE approval and will be launched in Europe. Embolic protection ...
A subset analysis of diabetic patients in the SPIRIT II Clinical trial of the XIENCE V Everolimus Eluting Stent System ...
Abbott Vascular says it will begin launching its XIENCE V stent system immediately in most European countries, focusing ...
The i-STAT BNP cartridge is a point of care diagnostic test used to assess the level of BNP (brain naturietic peptide) ...
Abbott Vascular has two embolic protection systems: the Emboshield and the RX ACCUNET. A filter-based device, Emboshield ...
Engineered specifically for the carotid artery, Xact’s closed-cell, tight-mesh design allows for a high coverage area ...
Abbott received FDA clearance to market its StarClose Vascular Closure System, a new vessel closure device engineered to ...
Designed to help physicians access areas of blockage in the coronary arteries and other vessels in the body that may be ...